Hypericum

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042

In the MGH study (N=125), no HAM-D-17 anxiety/somatization item reached significance after Bonferroni correction in any treatment arm (fluoxetine, hypericum, or placebo), despite nominal significance

Effect: null; best: anxiety-psychic in fluoxetine arm p=0.026; somatic-GI in hypericum arm p=0.042